Muhammad Jaffer, MD
Muhammad Jaffer, MD
Specialty: Neurology
Program: Neuro-Oncology
Language(s): English
-
Overview
Cancer Focus:
Brain Cancer, Glioblastoma, Meningioma, NeurofibromatosisDr. Jaffer received his MD degree from the University of South Florida, Morsani College of Medicine. He then went on to complete a Neurology Residency at the same institution, serving as the Academic Chief Resident of his program. Most recently, he completed a Clinical Neurophysiology Fellowship, also at the University of South Florida, Morsani College of Medicine.
Dr. Jaffer’s clinical interest is in onco-neurological complications, especially as relates to epilepsy syndromes, myopathies, and neuropathies. He is interested in multimodal clinical research that combines the use of patient parameters with EMG/EEG findings to predict neurologic outcomes and prognosis. Dr. Jaffer also has an interest in quality improvement research, particularly systems-based root cause analysis.
-
Publications
- Martinez Salazar A, Mokhtari S, Peguero E, Jaffer M. The Role of Complement in the Pathogenesis and Treatment of Myasthenia Gravis. Cells. 2025 May.14(10). Pubmedid: 40422242. Pmcid: PMC12110157.
- Mokhtari S, Asquith JM, Kareem SS, Bachmeier CA, Pina Y, Faramand RG, Kim Y, Peguero EN, Sahebjam S, Jaffer MH, Iacono DP, Jain MD, Vogelbaum MA, Davila ML, Forsyth PA, Locke FL, Lazaryan A. Intravenous Immunoglobulin (IVIG) for Patients with Severe Neurotoxicity Associated with Chimeric Antigen Receptor T-Cell (CAR-T) Therapy. Int J Mol Sci. 2025 Apr.26(8). Pubmedid: 40332772. Pmcid: PMC12028060.
- Boldig C, Warman M, Chavez J, Dubey D, Abukhdeir A, Iacono D, Verma N, Jaffer M, Teeling A, DeLuca K, Riedel H, Mokhtari S. A case of chronic lymphocytic leukemia with a paraneoplastic neurologic syndrome and leptomeningeal disease. Discov Med (Cham). 2024 Nov.1(120).
- Verma N, Jaffer MH, Kolli AS, Mokhtari S. Updates in the Management of Paraneoplastic Syndrome. Semin Neurol. 2024 Feb.44(1):36-46. Pubmedid: 38183975.
- Chen YC, Jaffer M, Zhou L, Moslehi J, Forsyth PA, Fecher LA. A Brain, A Heart, and the Courage: Balancing Benefit and Toxicity of Immunotherapy in Melanoma. Am Soc Clin Oncol Educ Book. 2023 May.43:e390594. Pubmedid: 37229626.
- Verma N, Jaffer M, Pina Y, Peguero E, Mokhtari S. Rituximab for Immune Checkpoint Inhibitor Myasthenia Gravis. Cureus. 2021 Jul.13(7):e16337. Pubmedid: 34395120. Pmcid: PMC8357079.
- Jaffer M, Chung M, Sharda E, Ramsakal A, Peguero E, Verma N, Mokhtari S. Immunotherapy Induced Myasthenic-Like Syndrome in a Metastatic Melanoma Patient With Amyotrophic Lateral Sclerosis. Clin Med Insights Oncol. 2020 Dec.14. Pubmedid: 33447124. Pmcid: PMC7780164.
- Chung M, Jaffer M, Verma N, Mokhtari S, Ramsakal A, Peguero E. Immune checkpoint inhibitor induced anti-glutamic acid decarboxylase 65 (Anti-GAD 65) limbic encephalitis responsive to intravenous immunoglobulin and plasma exchange. J Neurol. 2020 Apr.267(4):1023-1025. Pubmedid: 31832829.
-
Patient Comments
-
Awards and Expertise
Voted top doctor in Neurology in Tampa Magazine’s Top Doctors 2025.
90 patients rated this provider
The Provider Rating is an average of all responses to specific care provider-related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5 with 5 being the best score.
Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Learn more about our patient satisfaction surveyComments
Comments are gathered from specific care provider-related questions from our Patient Satisfaction Survey . The comments are submitted by patients and reflect their views and opinions. Patients are de-identified for confidentiality and patient privacy.
Learn more about our patient comments
We post both positive and negative comments from the surveys. We do not post comments that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may risk the privacy of our patients. A “[…]” in the comments below indicates de-identified patient information or comments that are unrelated to the patient’s experience with the visit to the provider, such as comments related to another provider, about the survey itself, or otherwise completely off-topic.
Provider Ratings and comments are gathered from our nationally-recognized Press Ganey Patient Satisfaction Survey. If a provider does not have ratings or comments listed it can be for several reasons, including:
Learn more about our patient satisfaction survey, ratings and comments